Trial Profile
A phase I study of Valbenazine for the treatment of Huntington's disease
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 01 Aug 2016
Price :
$35
*
At a glance
- Drugs Valbenazine (Primary)
- Indications Huntington's disease
- Focus Adverse reactions
- 01 Aug 2016 New trial record